Isolated organ perfusion does not result in systemic microembolization of tumor cells

Annals of Surgical Oncology

Volumn 6, Issue 7, 1999, Pages 658-663

  Wu, Peter C ^a,b   McCart, Andrea ^a   Hewitt, Stephen M ^a   Turner, Ewa ^a   Libutti, Steven K ^a   Bartlett, David L ^a   Alexander, H Richard ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Carcinoembryonic antigen; Isolated organ perfusion; RT PCR; Tumor microembolization; Tyrosinase

Indexed keywords

BETA ACTIN; CARCINOEMBRYONIC ANTIGEN; MELPHALAN; MONOPHENOL MONOOXYGENASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RECURRENCE; CANCER SCREENING; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIC THERAPY; LIMB TUMOR; LIVER CANCER; MELANOMA; METASTASIS; ORGAN PERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0032728552     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0658-3     Document Type: Article

References (25)

1. Lienard D, Ewalenko P, Delmotte JJ, et al. High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52-60.
2. Lienard D, Eggermont AM, Schraffordt-Koops H, et al. Isolated perfusion of the limb with high-dose tumor necrosis factor, interferon gamma and melphalan for melanoma stage III: results of a multicentre pilot study. Melanoma Res 1994;4:21-6.
3. Eggermont AMM, Koops HS, Liénard D, et al. Isolated limb perfusion with high dose tumor necrosis factor-α in combination with interferon-gamma and melphalan for irresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 1996;14: 2653-65.
4. Eggermont AM, Schraffordt KH, Klausner JM, et al. Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas. Cancer Treat Res 1997; 91:189-203.
5. Alexander HR, Bartlett DL, Libutti SK. Isolated hepatic perfusion: a potentially effective treatment for patients with metastatic or primary cancers confined to the liver. Cancer J Sci Am 1998;4:2-11.
6. Alexander HR, Bartlett DL, Libutti SK, et al. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998;16:1479-89.
7. Klaase JM, Kroon BBR, van Geel AN, et al. Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion using melphalan. Surgery 1994;115:39-45.
8. Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991;338:1227-9.
9. Pittman K, Burchill S, Smith B, et al. Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 1996; 7:297-301.
10. Jung FA, Buzaid AC, Ross MI, et al. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J Clin Oncol 1997;15:2826-31.
11. Glaser R, Rass K, Seiter S, et al. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 1997;15:2818-25.
12. Bostick PJ, Hoon DS, Cote RJ. Detection of carcinoembryonic antigen messenger RNA in lymph nodes from patients with colorectal cancer. N Engl J Med 1998;339:1643-4.
13. Gerhard M, Johl H, Kalthoff H, et al. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725-9.
14. Mori M, Mimori K, Ueo H, et al. Clinical significance of molecular detection of carcinoma cell in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16:128-32.
15. Seiden MV, Kantoff PW, Krithivas K, et al. Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 1994;12:2634-9.
16. Peck K, Sher YP, Shih JY, et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients. Cancer Res 1998;58:2761-5.
17. Ko Y, Klinz M, Totzke G, et al. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. Clin Cancer Res 1998;4:2141-6.
18. Thom AK, Alexander HR, Andrich MP, et al. Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion (ILP) with high-dose TNF, interferon-gamma and melphalan. J Clin Oncol 1995;13:264-73.
19. Hanckom GS, Johnson CA, Kidson SH. An improved and combined reverse transcription-polymerase chain reaction assay for reliable detection of metastatic melanoma cells in peripheral blood. Melanoma Res 1997;7:111-6.
20. Foss AJ, Guille MJ, Occleston NL, et al. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction. Br J Cancer 1995;72:155-9.
21. Daly JM, Kemeny NE. Metastatic cancer to the liver. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia: Lippincott-Raven, 1997:2551-70.
22. Jonas W, Windeatt S, O-Boateng A, et al. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 1996;39:717-21.
23. Mellado B, Colomer D, Castel T, et al. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 1996;14:2091-7.
24. Zhang Y, Zippe CD, VanLente F, et al. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells. Clin Cancer Res 1999;3:1215-20.
25. Henke W, Jung M, Jung K, et al. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer 1999;70:52-6.